LYTIR

Company · NEPH

Nephros, Inc.

Name as listed on its exchange; filed with the SEC as NEPHROS INC.

Nasdaq's symbol directory lists NEPH on Nasdaq as “Nephros, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 2 occasions ($22K); 3 filings by holders of 5% or more; 3 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Arthur H. Amron bought on 2 days latest Nov 17, 2026 bought $22K
Every trade (2)
  1. BUYArthur H. Amron bought Nov 17, 2026 2,500 shares filing $7K
  2. BUYArthur H. Amron bought Nov 16, 2026 5,000 shares filing $15K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Topline Capital Management, LLC filed Nov 16, 2026 Schedule 13G/A passive filing 6.4%
  2. Charles E. Davidson filed Sep 16, 2026 Schedule 13G passive filing 5.68%
  3. Wexford Capital LP filed Sep 16, 2026 Schedule 13D/A may seek influence 223,539 shares filing 2.06%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Departure or appointment of directors or officers filing Nov 17, 2026
  2. Results of operations and financial condition filing Nov 5, 2026
  3. Shareholder director nominations; Other events filing Oct 13, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.